Related Experiment Video

Updated: Jun 8, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in

Konstantin Krasagakis1, Irene Fragiadaki, Maria Metaxari

  • 1Department of Dermatology, Faculty of Medicine, University of Crete, Heraklion, Greece. krasagak@med.uoc.gr

Journal of Cellular Physiology
|September 22, 2010
PubMed

Insights

Stem cell factor (SCF) and KIT receptor signaling drive Merkel cell carcinoma (MCC) growth. Inhibiting SCF/KIT pathways, including AKT and ERK, halts MCC cell proliferation, suggesting therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Co-expression of KIT receptor and stem cell factor (SCF) is observed in Merkel cell carcinoma (MCC).
  • The functional role of SCF/KIT signaling in MCC pathogenesis remains unclear.

Purpose of the Study:

  • To investigate the expression and functional effects of SCF and KIT in the MCC-1 cell line.
  • To elucidate the role of SCF/KIT signaling in MCC cell growth and identify potential therapeutic targets.

Main Methods:

  • Assessed endogenous SCF and KIT expression in MCC-1 cells.
  • Evaluated the impact of exogenous SCF, anti-KIT antibodies, and kinase inhibitors (imatinib, nilotinib, U0126, wortmannin, LY294002) on MCC-1 cell proliferation and signaling pathways (KIT, AKT, ERK).

Main Results:

  • MCC-1 cells co-express SCF and KIT.
  • Exogenous SCF enhanced MCC-1 cell growth and activated KIT, AKT, and ERK signaling.
  • Neutralization of SCF/KIT signaling via antibodies or kinase inhibitors reduced MCC-1 cell proliferation.
  • Inhibition of downstream effectors AKT and ERK also decreased cell proliferation.

Conclusions:

  • KIT receptor is activated by autocrine or paracrine SCF, promoting MCC growth in vitro.
  • Targeting KIT and its downstream signaling pathways (AKT, ERK) offers a promising therapeutic strategy for MCC.

More Related Videos

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates08:19

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates

Published on: April 22, 2019

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...